3bgl: Difference between revisions
Jump to navigation
Jump to search
m Protected "3bgl" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3bgl.png|left|200px]] | [[Image:3bgl.png|left|200px]] | ||
{{STRUCTURE_3bgl| PDB=3bgl | SCENE= }} | {{STRUCTURE_3bgl| PDB=3bgl | SCENE= }} | ||
===Hepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors=== | ===Hepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors=== | ||
{{ABSTRACT_PUBMED_18155906}} | {{ABSTRACT_PUBMED_18155906}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[HMG-CoA Reductase]] | *[[HMG-CoA Reductase|HMG-CoA Reductase]] | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:018155906</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Finzel, B C.]] | [[Category: Finzel, B C.]] | ||
[[Category: Park, W K.C.]] | [[Category: Park, W K.C.]] | ||
[[Category: Pavlovsky, A.]] | [[Category: Pavlovsky, A.]] | ||
[[Category: Cholesterol biosynthesis]] | [[Category: Cholesterol biosynthesis]] | ||
[[Category: Endoplasmic reticulum]] | [[Category: Endoplasmic reticulum]] | ||
| Line 40: | Line 28: | ||
[[Category: Oxidoreductase]] | [[Category: Oxidoreductase]] | ||
[[Category: Peroxisome]] | [[Category: Peroxisome]] | ||
[[Category: Statin]] | [[Category: Statin]] | ||
[[Category: Steroid biosynthesis]] | [[Category: Steroid biosynthesis]] | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
Revision as of 03:46, 27 July 2012
Hepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitorsHepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors
Template:ABSTRACT PUBMED 18155906
About this StructureAbout this Structure
3bgl is a 4 chain structure of HMG-CoA Reductase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Park WK, Kennedy RM, Larsen SD, Miller S, Roth BD, Song Y, Steinbaugh BA, Sun K, Tait BD, Kowala MC, Trivedi BK, Auerbach B, Askew V, Dillon L, Hanselman JC, Lin Z, Lu GH, Robertson A, Sekerke C. Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1151-6. Epub 2007 Dec 5. PMID:18155906 doi:10.1016/j.bmcl.2007.11.124